FDA Recommends Additional Warning On Avian Flu Test Labels
This article was originally published in The Gray Sheet
Executive Summary
An FDA guidance document advises that language be added to labels of tests for detecting influenza A, or avian flu, stating that negative results should be confirmed with a cell culture
You may also be interested in...
FDA’s Pandemic Flu Plan Will Expedite Meetings With Diagnostic Sponsors
FDA's "1Pandemic Influenza Preparedness Strategic Plan," released March 14, calls for CDRH to expedite review of applications for new influenza diagnostics
FDA’s Accelerated Review Of Flu Test Offers A Model For Future Products
FDA's rapid review of a laboratory test that can aid in the diagnosis of avian influenza demonstrates a pathway that could be used for the introduction of other much-needed diagnostics, the agency suggests
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”